1- Department of Biochemistry, D.Y. Patil Medical College, Kolhapur, Maharashtra, India , dipalimangave1878@gmail.com
2- Department of Biochemistry, D.Y. Patil Medical College, Kolhapur, Maharashtra, India
2- Department of Biochemistry, D.Y. Patil Medical College, Kolhapur, Maharashtra, India
Abstract: (311 Views)
Background: Type II Diabetes mellitus is a chronic metabolic disorder characterized by insulin resistance and pancreatic β-cell dysfunction. Amylase and lipase are digestive enzymes secreted by the acinar cells of the exocrine pancreas. Pancreatic β-cell dysfunction in diabetes can impair exocrine pancreatic function. In the present study, we examined the correlation between serum amylase and lipase levels in subjects with type II diabetes mellitus. As lipase is a specific marker of pancreatic inflammation, its correlation with amylase may indicate specific inflammation of pancreatic cells in type II diabetes mellitus.
Methods: A cross-sectional, observational, and analytical study was conducted among patients who visited the medicine OPD. The study included 100 subjects, comprising healthy controls (n = 50) and patients with diabetes (n = 50). Random Blood Sugar (RBS), serum amylase, and serum lipase levels were measured enzymatically. The collected data were analyzed using Student’s t-test and Pearson’s correlation in SPSS version 29.
Results: Serum amylase levels were significantly higher in the type II diabetes mellitus case group (149.63 ± 99.97 IU/L) than in the healthy control group (56.39±19.49) (p < 0.001). Serum lipase levels were also significantly higher in the type II diabetes mellitus group (163.22 ± 127.57 IU/L) than in the healthy control group (48.08 ± 9.31) (p < 0.001). A strong positive correlation was observed between serum amylase and lipase levels in the type II diabetes mellitus case group (r = +0.22), whereas the healthy control group showed almost no correlation (r =+0.02).
Conclusion: The study suggests that elevated serum amylase and lipase levels in patients with Type II diabetes mellitus indicate pancreatic exocrine dysfunction and are associated with pancreatic β-cell endocrine function. Monitoring pancreatic exocrine function in patients with type II diabetes is crucial for predicting, preventing, assessing, and managing associated complications.
Methods: A cross-sectional, observational, and analytical study was conducted among patients who visited the medicine OPD. The study included 100 subjects, comprising healthy controls (n = 50) and patients with diabetes (n = 50). Random Blood Sugar (RBS), serum amylase, and serum lipase levels were measured enzymatically. The collected data were analyzed using Student’s t-test and Pearson’s correlation in SPSS version 29.
Results: Serum amylase levels were significantly higher in the type II diabetes mellitus case group (149.63 ± 99.97 IU/L) than in the healthy control group (56.39±19.49) (p < 0.001). Serum lipase levels were also significantly higher in the type II diabetes mellitus group (163.22 ± 127.57 IU/L) than in the healthy control group (48.08 ± 9.31) (p < 0.001). A strong positive correlation was observed between serum amylase and lipase levels in the type II diabetes mellitus case group (r = +0.22), whereas the healthy control group showed almost no correlation (r =+0.02).
Conclusion: The study suggests that elevated serum amylase and lipase levels in patients with Type II diabetes mellitus indicate pancreatic exocrine dysfunction and are associated with pancreatic β-cell endocrine function. Monitoring pancreatic exocrine function in patients with type II diabetes is crucial for predicting, preventing, assessing, and managing associated complications.
References
1. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2009;32(Suppl 1):S62-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Kaabi JA. Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2020;10(1):107-11. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Ramachandran A, Snehalatha C, Latha E, Vijay V, Viswanathan M. Rising prevalence of NIDDM in an urban population in India. Diabetologia. 1997;40(2):232-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. Tanv N-E-J, Akhte QS, Nahar S, Sumi MN, Hosen M. Serum amylase and lipase levels in type 2 diabetes mellitus. J Bangladesh Soc Physiol. 2017;12(2):52-6. [View at Publisher] [Google Scholar]
5. Pap A. Effect of insulin and glucose metabolism on pancreatic exocrine function. Int J Diabetes and Metabolism. 2004;12(3):30-4. [View at Publisher] [DOI] [Google Scholar]
6. Jain R, Jain PK, Mangukiya K. Study of serum amylase "in the patients of type 2 diabetes mellitus. Int J Sci Nat. 2014;5(3):553-6. [View at Publisher]
7. Chakraborty PP, Chowdhury S. A Look Inside the Pancreas: The "Endocrine-Exocrine Cross-talk". Endocrinol Metab Synd. 2015;4(1):1-4. [View at Publisher] [DOI] [Google Scholar]
8. Hackert T, Schütte K, Malfertheiner P. The Pancreas: Causes for Malabsorption. Viszeralmedizin. 2014;30(3):190-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Nakajima K, Nemoto T, Muneyuki T, Kakei M, Fuchigami H, Munakata H. Low serum amylase in association with metabolic syndrome and diabetes: A community-based study. Cardiovasc Diabetol. 2011;10:34. [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Ata N, Dal K, Kucukazman M, Yeniova AO, Karakaya S, Unsal O. The effect of glycemic control on CEA, CA 19-9, amylase and lipase levels. Open Med (Wars). 2014;10(1):8-13. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Kumar A, Itagi AS, Chetan TL, Neeralagi S. Study of serum amylase levels in patients with type 2 diabetes mellitus in atertiary care hospital. Asian J Med Res. 2022;11(2):1-6. [View at Publisher]
12. Hayden MR, Patel K, Habibi J, Gupta D, Tekwani SS, Whaley-Connell A, et al . Attenuation of endocrine-exocrine pancreatic communication in type 2 diabetes: pancreatic extracellular matrix ultrastructural abnormalities. J Cardiometab Syndr. 2008;3(4):234-43. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. Nakajima K, Oshida H, Muneyuki T, Kakei M. Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency. Core Evid. 2012;7:77-91. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Struyvenberg MR, Martin CR, Freedman SD. Practical guide to exocrine pancreatic insufficiency - breaking the myths. BMC Med. 2017;15(1):29. [View at Publisher] [DOI] [PMID] [Google Scholar]
15. Hahn J-U, Kerner W, Maisonneuve P, Lowenfels AB, Lankisch PG. Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1diabetes mellitus. Pancreas. 2008;36(3):274-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122. [View at Publisher] [DOI] [PMID] [Google Scholar]
17. Abstracts of paper submitted to the joint 40th anniversary meeting of American pancreatic association and japan pancreas society, November 4Y7,2009,Honolulu, Hawaii. 2009;38(8):980-1067. [View at Publisher] [Google Scholar]
18. Steinberg WM, Nauck MA, Zinman B, Daniels GH, Bergenstal, RM, Mann JFE, et al. LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial. Pancreas. 2014;43(8):1223-31. [View at Publisher] [DOI] [PMID] [Google Scholar]
19. Yadav R, Bhartiya JP, Verma SK, Nandkeoliar MK. The evaluation of serum amylase in the patients of type 2 diabetes mellitus, with a possible correlation with the pancreatic functions. J Clin Diagn Res. 2013;7(7):1291-4. [View at Publisher] [DOI] [PMID] [Google Scholar]
20. Madole MB, Iyer CM, Madivalar MT, Wadde SK, Howale DS. Evaluation of Biochemical Markers Serum Amylase and Serum Lipase for the Assessment of Pancreatic Exocrine Function in Diabetes Mellitus. J Clin Diagn Res. 2016;10(11): BC01-BC04. [View at Publisher] [DOI] [PMID] [Google Scholar]
21. Pierzynowski SG, Gregory PC, Filip R, Woliński J, Pierzynowska KG. Glucose homeostasis dependency on acini-islet-acinar (AIA) axis communication: a new possible pathophysiological hypothesis regarding diabetes mellitus. Nutr Diabetes. 2018;8(1):55. [View at Publisher] [DOI] [PMID] [Google Scholar]
22. Manjula KS, Reena R, Usha SMR, Priyadarshini KS, Shetty HV. Insight into the exocrine pancreatic function (serum amylase and lipase) in type 2 diabetes mellitus. Int J Clin Biochem Res. 2018;5(3):379-82. [View at Publisher] [DOI]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).
